GENEVA, July 18 -- ADARX PHARMACEUTICALS, INC. filed a patent application (US2025/056318) for “SOD1-MODULATING OLIGONUCLEOTIDES FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES”. With publication no. WO/2026/112274, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....